Form 4 for XYL Xylem Inc.
Accepted 2024-06-11 00:00:00 ET · period of report 2024-06-10 · accession 0001562180-24-004944 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-06-11 | 2024-06-10 | XYL | McShane Geri-Michelle | VP, CAO, Ctrl | M - OptEx | $74.71 | +1,766 | 5,067 | +53% | +$131.9K |
| D | 2024-06-11 | 2024-06-10 | XYL | McShane Geri-Michelle | VP, CAO, Ctrl | S - Sale+OE | $138.63 | -2,278 | 3,536 | -39% | -$315.8K |
| DM | 2024-06-11 | 2024-06-10 | XYL | McShane Geri-Michelle | VP, CAO, Ctrl | M - OptEx | $0.00 | -1,766 | 747 | -70% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-10 | M | A | 747 | $74.07 | 5,814 | D | — | — | |
| 2 | Common | Common Stock | 2024-06-10 | M | A | 1,019 | $75.18 | 5,067 | D | — | — | |
| 3 | Common | Common Stock | 2024-06-10 | S | D | 2,278 | $138.63 | 3,536 | D | — | — | (F1) This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 2,278 Shares were executed at a range of prices from $138.62 to $138.65. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
| 4 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2024-06-10 | M | D | 1,019 | $0.00 | 1,019 | D | $75.18 · — to 2028-02-21 | 1,019 Common Stock | (F2) The February 21, 2018 option grant vested one third on February 21, 2019, February 21, 2020, and February 21, 2021. |
| 5 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2024-06-10 | M | D | 747 | $0.00 | 747 | D | $74.07 · — to 2029-02-20 | 747 Common Stock | (F3) The February 20, 2019 option grant vested one third on February 20, 2020, February 20, 2021, and February 20, 2022. |